208 related articles for article (PubMed ID: 26049122)
1. Transdiaphragmatic cardiophrenic lymph node resection for Stage IV ovarian cancer.
LaFargue CJ; Bristow RE
Gynecol Oncol; 2015 Sep; 138(3):762-3. PubMed ID: 26049122
[No Abstract] [Full Text] [Related]
2. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
Cowan RA; Tseng J; Murthy V; Srivastava R; Long Roche KC; Zivanovic O; Gardner GJ; Chi DS; Park BJ; Sonoda Y
Gynecol Oncol; 2017 Nov; 147(2):262-266. PubMed ID: 28888540
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer.
Prader S; Harter P; Grimm C; Traut A; Waltering KU; Alesina PF; Heikaus S; Ataseven B; Heitz F; Schneider S; du Bois A
Gynecol Oncol; 2016 May; 141(2):271-275. PubMed ID: 26972337
[TBL] [Abstract][Full Text] [Related]
4. Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study.
Lopes A; Rangel Costa RL; di Paula R; Anton C; Calheiros Y; Sartorelli V; Kanashiro YM; de Lima JA; Yamada A; Pinto GLS; Vianna MR; Nogueira Dias Genta ML; Ribeiro U; Dos Santos MO
Int J Gynecol Cancer; 2019 Jan; 29(1):188-194. PubMed ID: 30640703
[TBL] [Abstract][Full Text] [Related]
5. Transdiaphragmatic cardiophrenic lymph node resection in a patient with an advanced-stage ovarian cancer.
Turkmen O; Kilic F; Ersak B; Kimyon Comert G; Ayhan S; Ozdemir M; Turan T
J Obstet Gynaecol; 2022 Apr; 42(3):527-529. PubMed ID: 34379542
[No Abstract] [Full Text] [Related]
6. Regional variation in surgical assessment of lymph nodes for staging among women with early-stage epithelial ovarian cancer.
Ulanday KT; Ward KK; Macera CA; Ji M; Plaxe SC
Gynecol Oncol; 2014 Feb; 132(2):411-5. PubMed ID: 24246773
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
[TBL] [Abstract][Full Text] [Related]
8. State of the art of surgery in advanced epithelial ovarian cancer.
Hacker NF
Ann Oncol; 2013 Dec; 24 Suppl 10():x27-32. PubMed ID: 24265399
[No Abstract] [Full Text] [Related]
9. Defining the optimal lymphadenectomy cut-off value in epithelial ovarian cancer staging surgery utilizing a mathematical model of validation.
Pereira A; Irishina N; Pérez-Medina T; Magrina JF; Magtibay PM; Kovaleva A; Rodríguez-Tapia A; Iglesias E
Eur J Surg Oncol; 2013 Mar; 39(3):290-6. PubMed ID: 23290581
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of Transabdominal Cardiophrenic Lymphnode Dissection in Advanced Ovarian Cancer: Initial Experience at a Tertiary Center.
Garbi A; Zanagnolo V; Colombo N; Aletti G; Achilarre MT; Bocciolone L; Landoni F; Rizzo S; Biffi R; Maggioni A
Int J Gynecol Cancer; 2017 Jul; 27(6):1268-1273. PubMed ID: 28498236
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic value of lymphadenectomy in ovarian cancer patients].
Gmyrek L; Jońska-Gmyrek J; Żółciak-Siwińska A
Ginekol Pol; 2014 Oct; 85(10):788-91. PubMed ID: 25546932
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer.
Ataseven B; Grimm C; Harter P; Prader S; Traut A; Heitz F; du Bois A
Gynecol Oncol; 2014 Dec; 135(3):435-40. PubMed ID: 25312398
[TBL] [Abstract][Full Text] [Related]
13. The effect of lymphadenectomy in advanced ovarian cancer according to residual tumor status: A population-based study.
Zhou J; Zhang WW; Zhang QH; He ZY; Sun JY; Chen QH; Wu SG
Int J Surg; 2018 Apr; 52():11-15. PubMed ID: 29432972
[TBL] [Abstract][Full Text] [Related]
14. Left cardiophrenic lymph node resection for advanced ovarian cancer with adhesion to the thoracic cavity.
Matsuoka A; Tate S; Nishikimi K; Shozu M
Gynecol Oncol; 2018 Nov; 151(2):390-391. PubMed ID: 30269869
[No Abstract] [Full Text] [Related]
15. Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma.
Takei Y; Takahashi S; Machida S; Taneichi A; Yoshiba T; Takahashi Y; Yoshida C; Saga Y; Matsubara S; Fujiwara H
Int J Clin Oncol; 2018 Oct; 23(5):930-935. PubMed ID: 29679177
[TBL] [Abstract][Full Text] [Related]
16. Cardiophrenic lymph node resection in advanced ovarian cancer: surgical outcomes, pre- and postoperative imaging.
Salehi S; Mohammar R; Suzuki C; Joneborg U; Hjerpe E; Torbrand C; Falconer H
Acta Oncol; 2018 Jun; 57(6):820-824. PubMed ID: 29182048
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer.
Gouy S; Goetgheluck J; Uzan C; Duclos J; Duvillard P; Morice P
Eur J Surg Oncol; 2012 Feb; 38(2):170-5. PubMed ID: 22104389
[TBL] [Abstract][Full Text] [Related]
18. Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: review of a single-institution experience.
Ulker V; Kuru O; Numanoglu C; Akbayır O; Polat I; Uhri M
Arch Gynecol Obstet; 2014 May; 289(5):1087-92. PubMed ID: 24213097
[TBL] [Abstract][Full Text] [Related]
19. The safety and feasibility of robotic-assisted lymph node staging in early-stage ovarian cancer.
Brown JV; Mendivil AA; Abaid LN; Rettenmaier MA; Micha JP; Wabe MA; Goldstein BH
Int J Gynecol Cancer; 2014 Oct; 24(8):1493-8. PubMed ID: 25078341
[TBL] [Abstract][Full Text] [Related]
20. Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Martinez A; Pomel C; Mery E; Querleu D; Gladieff L; Ferron G
Gynecol Oncol; 2011 May; 121(2):258-63. PubMed ID: 21295334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]